Vaughan David Investments’s Novo Nordisk NVO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,695	Closed	-$202K	–	216
2024 Q3	$202K	Buy	1,695 +8	+0.5%	+$953	﹤0.01%	211
2024 Q2	$241K	Sell	1,687 -79	-4%	-$11.3K	0.01%	193
2024 Q1	$227K	Buy	+1,766	New	+$227K	0.01%	203